respiratori
infect
common
human
ill
worldwid
clinic
manifest
infect
vari
mild
selflimit
upper
respiratori
tract
infect
uri
common
cold
acut
respiratori
tract
infect
ari
acut
lower
respiratori
tract
infect
pneumonia
bronchiti
bronchiol
result
death
children
age
year
pneumonia
frequent
caus
death
kuhn
seventyf
percent
acut
ill
develop
countri
result
ari
approxim
viral
origin
mahoney
adult
may
averag
two
ari
per
year
young
children
may
experi
five
seven
viral
respiratori
infect
per
year
encyclopedia
public
health
emerg
viral
respiratori
pathogen
influenza
virus
swineorigin
human
coronaviru
cov
sarscov
caus
sever
acut
respiratori
syndrom
brought
new
focu
virolog
laboratori
role
clinic
diagnosi
time
report
viral
respiratori
infect
may
assist
select
appropri
therapi
avail
may
also
help
reduc
unnecessari
use
antibacteri
agent
improv
diagnost
also
play
import
role
infect
control
within
individu
institut
broadli
help
identifi
pathogen
prevent
spread
within
among
geograph
region
numer
diagnost
technolog
use
effort
antibodi
detect
often
limit
use
serolog
assay
reli
comparison
acut
convalesc
sera
prevent
rapid
diagnosi
rapid
enzym
immunoassay
eia
commerci
avail
influenza
influenza
b
respiratori
syncyti
viru
rsv
test
primarili
use
outpati
site
emerg
depart
due
rapid
turnaround
time
howev
suffer
limit
sensit
specif
past
decad
diagnosi
common
respiratori
virus
typic
involv
direct
examin
respiratori
specimen
use
fluoresc
antibodi
fa
inocul
sampl
variou
cell
line
grow
tube
recent
shell
vial
tube
cultur
allow
one
observ
cell
layer
period
sever
day
week
cytopath
effect
cpe
reflect
viral
growth
mani
common
respiratori
viral
pathogen
exhibit
typic
cpe
pattern
allow
presumpt
identif
confirm
viral
ident
may
made
use
fa
stain
cell
layer
sometim
ancillari
test
hemadsorpt
necessari
detect
identif
shell
vial
cultur
svc
allow
much
rapid
detect
svc
made
dram
vial
contain
coverslip
monolay
cell
cover
cultur
medium
respiratori
sampl
inocul
vial
centrifug
hasten
viral
attach
cell
layer
result
svc
usual
avail
day
fa
even
faster
hour
suffer
loss
sensit
compar
culturebas
method
techniqu
quit
laborintens
requir
highli
train
staff
perform
tube
cultur
method
remain
sensit
even
prolong
incub
may
miss
mani
infect
molecular
techniqu
commonli
exemplifi
polymeras
chain
reaction
pcr
variant
realtim
pcr
revers
transcriptas
rt
pcr
provid
opportun
vastli
improv
sensit
convent
method
mahoney
amplif
method
present
isotherm
method
nucleic
acid
sequencebas
amplif
nasba
loopmedi
isotherm
amplif
lamp
potenti
advantag
chapter
method
come
signific
challeng
howev
may
need
effect
simultan
detect
increasingli
broad
spectrum
respiratori
viral
pathogen
one
look
replac
fa
cultur
equat
minimum
seven
eight
individu
pcr
test
ad
newli
describ
agent
potenti
clinic
signific
increas
number
challeng
develop
valid
implement
broad
array
simultan
molecular
test
great
cost
may
well
prohibit
challeng
met
design
pcr
reaction
amplifi
detect
one
viral
target
simultan
multiplex
pcr
appar
solut
creat
anoth
set
challeng
number
reactant
primer
probe
target
intern
control
multiplex
reaction
increas
becom
difficult
optim
assay
maintain
sensit
specif
technic
boundari
also
present
number
individu
target
detect
singl
reaction
limit
number
report
molecul
distinguish
detect
instrument
adapt
limit
mani
laboratorydevelop
assay
lda
respiratori
virus
consist
seri
pcr
reaction
seri
may
compos
three
four
separ
pcr
assay
two
three
target
per
reaction
vessel
anoth
approach
may
use
newer
technolog
broaden
number
target
may
detect
follow
endpoint
amplif
method
discuss
follow
section
accur
detect
respiratori
virus
depend
collect
highqual
specimen
appropri
transport
storag
specimen
prior
laboratori
test
although
durat
viral
shed
depend
type
viru
well
type
infect
age
patient
rule
specimen
collect
earli
acut
phase
infect
ideal
first
day
onset
clinic
symptom
maxim
sensit
gener
respiratori
specimen
molecular
test
collect
handl
manner
viral
cultur
fa
test
specimen
diagnosi
upper
respiratori
viru
infect
includ
nasopharyng
aspir
nasopharyng
wash
nasopharyng
swab
throat
swab
collect
swab
specimen
commerci
avail
swab
made
rayon
dacron
polyest
nylon
accept
use
calcium
alginatetip
swab
toxic
virus
swab
wooden
handl
contain
toxin
formaldehyd
may
inhibit
detect
virus
recent
flock
swab
abudiab
et
al
chan
et
al
use
collect
larg
number
epitheli
cell
line
nasopharynx
flock
swab
tip
made
perpendicular
nylon
fiber
act
like
soft
brush
dislodg
epitheli
cell
sever
commerci
avail
media
suitabl
transport
respiratori
sampl
transport
medium
necessari
prevent
dri
sampl
maintain
viabil
viru
inhibit
growth
microbi
contamin
viral
transport
media
remel
lenexa
ks
requir
transport
transport
media
becom
avail
allow
roomtemperatur
storag
prior
use
well
transport
hour
specimen
collectionfor
exampl
remel
lenexa
ks
univers
transport
medium
room
temperatur
utmrt
copan
italia
brescia
itali
barger
et
al
nasopharyng
aspir
wash
histor
consid
prefer
specimen
detect
respiratori
virus
follow
nasopharyng
swab
larg
number
respiratori
epitheli
cell
obtain
proper
collect
nasopharyng
wash
aspir
method
recommend
hospit
patient
accur
diagnosi
critic
appropri
antivir
therapi
infect
control
measur
detect
rsv
particular
shown
improv
collect
wash
aspir
rather
swab
sung
et
al
recent
studi
children
suggest
use
flock
swab
transport
viral
transport
medium
provid
increas
specimen
qualiti
collect
swab
compar
sensit
nasopharyng
aspir
abudiab
et
al
chan
et
al
walsh
et
al
show
signific
differ
sensit
nasopharyng
aspir
transport
viral
transport
medium
nasopharyng
sampl
flock
swab
viral
transport
media
less
invas
flock
swab
specimen
would
attract
altern
nasopharyng
aspir
particularli
outpati
set
throat
swab
recommend
specimen
molecular
test
howev
molecular
techniqu
shown
increas
sensit
specimen
type
seen
cultur
antigen
detect
fiebelkorn
nolt
specimen
diagnosi
lower
respiratori
viru
infect
includ
bronchoalveolar
lavag
tracheal
aspir
pleural
fluid
lung
biopsi
small
biopsi
tissu
specimen
place
suitabl
transport
medium
prevent
dri
hospit
set
specimen
process
promptli
laboratori
larg
tissu
fluid
may
submit
without
addit
transport
medium
although
sputum
rel
easi
obtain
often
submit
laboratori
detect
lower
respiratori
tract
infect
virus
detect
sputum
may
actual
origin
oropharynx
addit
mucu
present
sputum
may
contain
inhibitor
decreas
sensit
molecular
test
best
specimen
laboratori
examin
depend
clinic
set
patient
well
site
infect
clinic
suspicion
uri
versu
lri
laboratori
method
analysi
use
clinic
suspicion
particular
viral
pathogen
may
also
affect
choic
exampl
optim
detect
sar
cov
sampl
upper
respiratori
tract
insensit
viral
detect
first
week
diseas
cov
viral
load
greater
lower
respiratori
tract
earli
period
infect
collect
type
sampl
may
creat
aerosol
danger
medic
staff
accord
center
diseas
control
prevent
cdc
first
week
infect
nasopharyng
oropharyng
specimen
plasma
serum
test
subsequ
nasopharyng
oropharyng
specimen
stool
use
mahoney
richardson
proper
specimen
collect
transport
major
step
molecular
assay
divid
nucleic
acid
extract
amplif
detect
examin
contribut
final
outcom
assay
discuss
separ
chapter
sever
commerci
extract
method
avail
rel
easi
perform
amplif
detect
typic
requir
time
attent
optim
purifi
viral
target
may
use
initi
work
optim
amplif
detect
step
howev
true
clinic
respiratori
sampl
also
process
order
evalu
matrix
effect
extract
method
assay
perform
intern
extern
control
dna
rna
appropri
ad
clinic
sampl
prior
extract
control
give
one
confid
patient
sampl
handl
appropri
throughout
assay
reactant
master
mix
capabl
produc
amplicon
nucleic
acid
amplif
test
naat
typic
sensit
convent
method
ie
cultur
immunofluoresc
detect
viral
respiratori
pathogen
mahoney
common
amplif
chemistri
pcr
rtpcr
requir
instrument
cycl
temperatur
step
amplif
process
method
nasba
lamp
isotherm
elimin
requir
differ
temperatur
amplif
detect
amplif
product
may
endpoint
realtim
natur
endpoint
determin
singl
measur
taken
amplif
reaction
complet
realtim
measur
amplif
product
perform
concurr
amplif
reaction
exampl
discuss
throughout
chapter
exampl
endpoint
realtim
measur
present
one
keep
mind
signific
advantag
realtim
pcr
amplif
detect
take
place
unopen
tube
therebi
reduc
risk
contamin
subsequ
falseposit
result
endpoint
detect
method
requir
postamplif
manipul
pcr
product
howev
time
amplif
tube
open
manual
manipul
amplicon
occur
happen
load
electrophoresi
gel
substanti
risk
carryov
contamin
discuss
naat
accompani
detect
method
use
success
detect
respiratori
virus
follow
host
differ
format
chemistri
repres
variou
assay
target
differ
number
virus
mani
lda
use
commerci
reagent
research
use
ruo
analytespecif
reagent
asr
sever
commerci
method
also
present
includ
current
clear
us
food
drug
administr
fda
vitro
diagnost
use
increas
use
molecular
techniqu
identif
respiratori
pathogen
abil
isol
viral
dna
rna
varieti
respiratori
specimen
becom
increasingli
import
dna
rna
degrad
enzymat
dnaand
rnaspecif
nucleas
dnase
rnase
proper
handl
sampl
first
step
ensur
isol
highqual
nucleic
acid
especi
import
purifi
rna
inher
instabl
rna
molecul
ubiquit
presenc
rnase
environ
common
sourc
rnase
contamin
bacteria
mold
introduc
sampl
contact
skin
contamin
laboratori
surfac
glove
worn
handl
sampl
reagent
process
done
use
asept
techniqu
biolog
safeti
cabinet
bleach
rins
alcohol
use
rnasefre
reagent
plastic
ware
use
unpreserv
sampl
process
promptli
upon
receipt
laboratori
frozen
walsh
et
al
number
freezethaw
cycl
minim
specimen
solut
extract
nucleic
acid
histor
nucleic
acid
extract
accomplish
use
timeconsum
phenolchloroformbas
procedur
follow
alcohol
precipit
number
manual
step
well
hazard
chemic
involv
procedur
limit
use
clinic
laboratori
boom
colleagu
report
extract
method
base
revers
bind
nucleic
acid
molecul
onto
silica
presenc
chaotrop
salt
exampl
guanidin
thiocyan
method
remov
endogen
nucleas
pcr
inhibitor
purifi
nucleic
acid
variou
type
clinic
sampl
boom
et
al
commerci
avail
extract
kit
autom
extract
platform
base
method
silica
coat
onto
membran
filter
magnet
particl
plastic
column
contain
silicaimpregn
filter
one
commonli
adopt
design
initi
cell
lysi
protein
digest
step
specimen
pass
filter
bind
nucleic
acid
residu
protein
polysaccharid
impur
present
solut
remov
wash
buffer
similar
method
base
principl
adsorpt
nucleic
acid
silicaco
magnet
particl
cell
lysi
addit
magnet
silica
bead
specimen
place
near
magnet
field
nucleic
acid
retain
bead
wash
step
depend
extract
protocol
salt
concentr
ph
final
wash
buffer
adjust
select
elut
dna
rna
total
nucleic
acid
qiagen
ideal
evalu
protocol
perform
viru
sampl
type
test
physic
properti
viru
exampl
rna
vs
dna
envelop
vs
nonenvelop
well
variat
sampl
type
number
cell
viral
load
presenc
mucu
inhibitor
must
consid
choos
extract
protocol
petrich
et
al
number
compani
offer
rang
autom
nucleic
acid
extract
system
suitabl
use
laboratori
high
medium
low
test
volum
smaller
less
costli
instrument
individu
packag
reagent
cartridg
handl
sampl
time
limit
sampl
manipul
select
autom
extract
equip
requir
consider
number
factor
includ
specimen
type
input
volum
elut
volum
eas
oper
versatil
cost
throughput
handson
time
technologist
even
autom
instrument
process
respiratori
sampl
difficult
due
presenc
mucu
sampl
nasopharyng
aspir
sputum
broncheoalveolar
lavag
variou
method
compar
date
standard
pretreat
method
disrupt
mucu
sampl
method
propos
includ
protocol
use
nacetylcystein
proteinas
k
qiagen
person
commun
dithiothreitol
sputasol
xiang
et
al
molecular
assay
rna
target
alon
assay
pretreat
mucoid
sampl
dnase
increas
rate
detect
deiman
et
al
pcrinhibit
substanc
mucu
often
extract
along
nucleic
acid
import
form
intern
control
use
extract
process
pcr
pcr
variant
repres
far
common
approach
singletarget
multiplex
assay
design
process
exponenti
amplifi
dna
target
sequenc
use
dna
polymeras
deoxyribos
nucleotid
dntp
targetspecif
primer
basic
step
includ
denatur
input
doublestrand
dna
dsdna
anneal
primer
elong
primer
sequenc
step
repeat
cycl
rna
viral
nucleic
acid
target
must
first
revers
transcrib
complementari
dna
cdna
begin
pcr
process
method
commonli
refer
revers
transcriptionpolymeras
chain
reaction
rtpcr
pcr
process
complex
constitu
amplif
reaction
influenc
effici
success
outcom
factor
concentr
primer
templat
dntp
magnesium
mg
type
polymeras
use
templat
g
c
content
cycl
paramet
must
balanc
optim
perform
detect
pcr
product
amplicon
size
separ
via
gel
electrophoresi
use
hybrid
sequencespecif
reporterlabel
probe
type
report
molecul
determin
detect
instrument
would
use
probe
detect
nest
pcr
modif
pcr
design
improv
sensit
specif
nest
pcr
involv
use
two
primer
set
two
success
pcr
reaction
first
set
primer
design
anneal
sequenc
upstream
second
set
primer
use
initi
pcr
reaction
amplicon
result
first
pcr
reaction
use
templat
second
set
primer
second
amplif
step
sensit
specif
dna
amplif
may
significantli
enhanc
techniqu
howev
potenti
carryov
contamin
reaction
typic
also
increas
due
addit
manipul
amplicon
product
minim
carryov
differ
part
process
physic
separ
one
anoth
prefer
entir
separ
room
amplicon
nest
pcr
assay
detect
manner
pcr
number
individu
pcr
reaction
need
detect
current
recogn
spectrum
common
viral
respiratori
pathogen
would
approxim
smaller
number
perhap
gener
regard
practic
clinic
import
number
may
vari
given
institut
depend
patient
demograph
season
geograph
locat
monoplex
pcr
reaction
virus
would
costli
laborintens
multiplex
reaction
gener
interest
potenti
mean
target
wide
rang
agent
maintain
practic
term
cost
eas
use
throughput
detect
respiratori
virus
singl
tube
would
ideal
mani
lda
seek
three
five
target
per
reaction
reflect
limit
optim
instrument
multiplex
reaction
requir
optim
paramet
mention
earlier
monoplex
reaction
howev
work
becom
complex
due
requir
maintain
sensit
specif
multipl
target
use
multipl
primer
pair
probe
optim
anneal
temperatur
monoplex
primer
set
may
significantli
differ
result
potenti
unequ
amplif
target
sequenc
competit
inhibit
reaction
compon
addit
templat
may
form
secondari
structur
interfer
effici
polymer
increas
product
nonspecif
product
particularli
primer
dimer
may
occur
overcom
problem
must
close
attent
primer
design
preferenti
amplif
individu
target
may
minim
primer
set
multiplex
reaction
design
common
optim
anneal
temperatur
ad
dimethyl
sulfoxid
dmso
addit
glycerol
bovin
serum
albumin
may
help
reduc
secondari
structur
target
sequenc
therebi
improv
polymer
effici
salt
concentr
buffer
enzym
concentr
proper
aliquot
storag
reagent
affect
success
multiplex
reaction
refer
avail
aid
one
design
troubleshoot
multiplex
pcr
assay
elnifro
et
al
markoulato
et
al
end
perform
characterist
assay
includ
diagnost
analyt
sensit
specif
precis
accuraci
must
verifi
laboratori
realtim
pcr
realtim
rtpcr
assay
becom
common
method
multiplex
detect
respiratori
virus
mani
recent
assay
use
technolog
sever
fluoresc
probe
chemistri
avail
use
two
commonli
describ
detect
respiratori
virus
molecular
beacon
probe
taqman
probe
label
fluoresc
report
molecul
end
quencher
molecul
end
target
present
quench
probe
hybrid
target
dna
polymeras
exonucleas
activ
digest
probe
report
molecul
therebi
freed
quencher
fluoresc
detect
giulietti
et
al
molecular
beacon
probe
also
contain
fluoresc
report
quencher
molecul
probe
construct
secondari
hairpinloop
structur
form
due
secondari
structur
fluoresc
report
quencher
molecul
brought
close
proxim
result
quench
fluoresc
target
present
probe
secondari
structur
relax
probe
hybrid
target
action
move
report
quencher
molecul
away
fluoresc
emit
anoth
type
chemistri
use
fluidic
microarray
gain
popular
recent
detect
respiratori
virus
method
multiplex
pcr
reaction
produc
amplicon
target
respiratori
viru
es
follow
remov
excess
primer
nucleotid
targetspecif
primer
tsp
contain
xtag
univers
tag
sequenc
ad
hybrid
complementari
target
amplicon
present
tsp
perfect
complementari
match
extend
biotindctp
incorpor
grow
strand
upon
complet
stage
reaction
introduc
colorcod
bead
contain
molecul
bind
univers
tag
extend
tsp
fluoresc
report
molecul
ad
reaction
bind
biotin
bead
analyz
flow
cytomet
colorcod
bead
specif
singl
viru
spectral
distinguish
virusspecif
bead
therefor
instrument
detect
presenc
viru
detect
fluoresc
via
report
molecul
determin
viru
es
present
via
virusspecif
bead
associ
fluoresc
luminex
molecular
diagnost
inc
toronto
canada
fig
anoth
pcr
chemistri
use
concert
fluoresc
bead
technolog
involv
use
iso
base
synthet
modifi
cytosin
guanin
structur
slightli
chang
specif
basepair
pair
natur
base
ic
ig
iso
base
still
recogn
dna
polymeras
easili
incorpor
newli
synthes
dna
first
pcr
reaction
one
primer
primer
set
singl
ic
terminu
extens
result
icproduct
hybrid
primer
targetspecif
extens
tse
contain
virusspecif
tag
tse
extend
biotinlabel
ig
incorpor
reaction
end
ic
terminu
fig
product
captur
detect
describ
earlier
virusspecif
bead
read
flow
cytomet
use
colorcod
bead
flow
cytometri
gener
potenti
detect
mani
virus
singl
reaction
current
done
method
describ
similiarli
solidphas
microarray
use
manner
consist
solid
support
glass
slide
silicon
wafer
matric
spot
larg
number
probe
spatial
arrang
coval
link
support
microarray
may
low
high
densiti
refer
number
sequenc
probe
affix
per
area
chip
lowdens
chip
may
applic
use
detect
respiratori
virus
given
rel
low
cost
eas
manufactur
method
primarili
target
rna
thu
especi
amen
detect
viral
respiratori
pathogen
nasba
employ
three
enzymesavian
myeloblastosi
viru
amv
revers
transcriptas
rna
polymeras
rnase
hand
two
primer
amv
revers
transcriptas
also
polymeras
activ
primer
contain
rna
polymeras
promot
target
amplicon
singlestrand
denatur
time
need
target
rna
target
isotherm
method
requir
thermal
cycler
thu
rapid
method
requir
temperatur
cycl
deiman
et
al
lamp
isotherm
method
use
four
targetspecif
primer
dna
polymeras
high
strand
displac
activ
bst
dna
polymeras
larg
fragment
perform
selfcycl
strand
displac
dna
polymer
primer
consist
set
two
inner
primer
forward
backward
two
outer
primer
forward
backward
inner
primer
contain
sequenc
sens
antisens
strand
target
dna
separ
spacer
figur
univers
tag
sequenc
fluidic
microarray
multiplex
pcr
perform
amplifi
viral
target
excess
nucleotid
primer
remov
use
shrimp
alkalin
phosphatas
exonucleas
viralspecif
primer
univers
tag
sequenc
link
end
ad
reaction
hybrid
take
place
complementari
sequenc
primer
extend
targetspecif
primer
extens
tspe
extens
product
contain
biotindctp
colorcod
microspher
ad
reaction
color
bead
antitag
sequenc
surfac
bind
specif
viral
target
strepavidinphycoerythrin
ad
strepavidin
bind
biotin
phycoerythrin
emit
fluoresc
bead
pass
singlefil
flow
cytomet
detect
chamber
instrument
use
two
laser
one
spectral
classifi
bead
detect
fluoresc
associ
bead
luminex
molecular
diagnost
inc
toronto
ontario
canada
permiss
figur
pcr
use
isoc
ic
iso
g
ig
base
rna
target
revers
transcrib
cdna
primer
anneal
one
primer
contain
ic
terminu
pcr
take
place
targetspecif
extens
primer
tse
viralspecif
tag
hybrid
amplifi
target
tse
extend
dna
polymeras
incorpor
biotinlabel
ig
opposit
ic
primer
colorcod
microspher
oligo
sequenc
complementari
viral
specif
tag
amplicon
captur
proper
amplicon
fluoresc
report
molecul
ad
reaction
bind
biotin
bead
pass
flow
cytomet
analyz
virusspecif
bead
bead
associ
fluoresc
posit
bioscienc
madison
wi
permiss
thymidin
strand
displac
take
place
prime
outer
primer
result
singlestrand
molecul
form
stemloop
cycl
proceed
larg
number
amplicon
approxim
copi
produc
less
hour
entir
lamp
reaction
take
place
lend
better
specif
might
seen
isotherm
method
nasba
take
place
notomi
et
al
fluoresc
probe
use
method
realtim
measur
desir
realtim
turbidimet
eiken
chemic
tokyo
japan
may
use
measur
turbid
everi
second
turbid
result
increas
product
magnesium
pyrophosph
posit
reaction
howev
realtim
turbidimet
avail
endpoint
measur
may
taken
ad
fluoresc
dye
eg
calcein
initi
reaction
contain
manganes
manganes
act
fluoresc
quencher
amplif
target
nucleic
acid
take
place
pyrophosph
ion
produc
bind
manganes
remov
quench
effect
free
calcein
fluoresc
excit
light
uv
transillumin
laboratori
without
thermal
cycler
realtim
detect
instrument
lamp
method
may
provid
viabl
altern
method
amplif
sever
investig
use
multiplex
assay
design
endpoint
analysi
detect
respiratori
virus
one
exampl
set
two
multiplex
rtpcr
reaction
use
simultan
detect
influenza
b
gel
electrophoresi
amplif
product
use
determin
type
influenza
present
method
prove
rapid
altern
cultur
lower
limit
detect
boonsuk
et
al
anoth
studi
nest
pcr
assay
use
detect
respiratori
virus
bacteria
involv
respiratori
tract
infect
lam
et
al
singl
multiplex
reaction
pathogen
would
sacrif
amplif
effici
therefor
five
separ
multiplex
reaction
use
four
five
pathogen
target
reaction
amplicon
analyz
use
gel
electrophoresi
allow
subtyp
pathogen
base
amplicon
size
method
prove
rapid
day
greater
sensit
specif
convent
method
abil
molecular
method
detect
organ
difficult
imposs
cultur
along
greater
sensit
produc
overal
posit
rate
nest
pcr
method
compar
culturebas
method
nest
pcr
method
also
detect
coinfect
seven
sampl
test
convent
method
detect
coinfect
lam
et
al
numer
investig
use
realtim
method
demonstr
variabl
improv
result
compar
cultur
twotub
multiplex
pcr
reaction
molecular
beacon
probe
design
detect
seven
virus
influenza
influenza
b
rsv
parainfluenza
templeton
et
al
respiratori
sampl
n
test
convent
cultur
multiplex
pcr
assay
nineteen
percent
sampl
posit
convent
method
posit
pcr
addit
pcrposit
sampl
confirm
pcr
assay
mean
cross
threshold
ct
valu
culturenegativepcrposit
sampl
indic
lower
viral
load
concord
sampl
mean
ct
p
also
two
dual
infect
detect
pcr
cultur
templeton
et
al
hyma
hillyard
use
realtim
pcr
method
detect
multipl
respiratori
virus
influenza
influenza
b
rsv
commerci
ruo
reagent
modifi
taqman
method
system
taqman
probe
still
report
molecul
quencher
also
minor
groov
bind
mgb
moieti
end
dnaprob
hybrid
produc
mgb
moieti
tuck
minor
groov
conform
stabil
duplex
protect
probe
hydrolysi
process
normal
occur
taqman
probe
modifi
taqman
hybrid
probe
product
hydrolyz
therefor
avail
melt
curv
analysi
hyma
hillyard
melt
temperatur
temperatur
half
popul
nucleic
acid
sequenc
singlestrand
melt
curv
analysi
result
melt
temperatur
specif
individu
amplicon
sequenc
temperatur
referenc
studi
influenza
influenza
b
rsv
respect
result
modifi
taqman
probe
melt
curv
analysi
show
concord
sampl
posit
cultur
fa
rtpcr
realtim
pcr
method
use
modifi
mgb
taqman
hybrid
probe
improv
sensit
due
detect
seven
posit
sampl
detect
three
method
presenc
seven
addit
posit
virus
confirm
pcr
assay
lee
et
al
select
adult
respiratori
sampl
posit
either
human
rhinoviru
hrv
rsv
parainfluenza
piv
influenza
infv
adenoviru
adv
convent
virolog
method
sampl
reanalyz
use
commerci
ruo
system
multiplex
pcr
anoth
commerci
ruo
system
detect
commerci
system
use
isoc
isog
microspher
flow
cytometri
target
eight
virus
hrv
rsv
piv
infv
adv
metapneumoviru
coronaviru
enteroviru
overal
sensit
specif
method
respect
addit
nasal
secret
symptomat
children
analyz
ruo
system
compar
cultur
fa
convent
method
detect
viru
sampl
multiplex
pcr
detect
viru
sampl
four
posit
sampl
found
two
virus
pcr
lee
et
al
yet
anoth
studi
rtpcr
lowdens
array
use
amplifi
influenza
rna
transcript
react
oligonucleotid
fix
glass
slide
accuraci
method
townsend
et
al
asr
ruo
fdaclear
reagent
kit
isotherm
amplif
method
nasba
lamp
unit
state
time
method
present
due
past
import
nasba
potenti
avail
futur
lamp
neither
two
isotherm
method
requir
cycl
differ
temperatur
primer
anneal
templat
elong
render
use
thermal
cycler
unnecessari
method
also
characterist
rapid
requir
thermal
cycl
studi
use
nasba
method
clinic
respiratori
sampl
nasopharyng
aspir
swab
sputa
bronchoalveolar
lavag
endotrach
aspir
assay
rsv
b
use
convent
fa
cultur
enzymelink
immunoassay
elisa
nasba
nasba
outperform
method
detect
rsv
sampl
versu
cultur
fa
perform
approxim
sampl
posit
rate
deiman
et
al
nasba
assay
sarscov
show
equival
sensit
compar
realtim
rtpcr
assay
nasba
potenti
advantag
term
throughput
take
hour
less
time
complet
rtpcr
keightley
et
al
commerci
method
use
lamp
technolog
yet
avail
unit
state
commerci
reagent
rna
amplif
sarscov
detect
lamp
eiken
chemic
tokyo
japan
avail
oversea
sever
investig
use
lamp
detect
respiratori
viral
pathogen
imai
et
al
use
lamp
technolog
detect
influenza
report
sensit
higher
reach
rtpcr
sensit
lamp
unchang
whether
use
endpoint
fluoresc
detect
realtim
turbidimetr
detect
cov
detect
use
lamp
method
three
set
primer
realtim
turbidimetr
detect
report
time
sensit
endpoint
qualit
rtpcr
follow
gel
electrophoresi
hong
et
al
overal
perform
compar
detect
cov
use
lamp
compar
quantit
realtim
pcr
assay
qrtpcr
sensit
qrtpcr
lamp
sensit
similar
sampl
submit
day
symptom
onset
sampl
n
taken
earli
day
onset
detect
rate
qrtpcr
lamp
although
studi
suggest
qrtpcr
sensit
method
earli
detect
sar
lamp
may
practic
cost
complex
standpoint
thermal
cycler
fluoresc
probe
realtim
instrument
need
therebi
suggest
valu
laboratori
resourcelimit
area
poon
et
al
three
commerci
kit
clear
fda
vitro
diagnost
use
detect
variou
group
respiratori
virus
nasopharyng
swab
symptomat
individu
januari
fda
clear
xtag
rvp
respiratori
viral
panel
luminex
toronto
canada
prodess
waukesha
wi
novemb
prodess
gain
fda
clearanc
kit
prodess
product
employ
realtim
rtpcr
taqman
probe
detect
influenza
influenza
b
rsv
singl
reaction
subtyp
influenza
rsv
detect
four
subtyp
hmpv
singl
reaction
specifi
type
present
xtag
rvp
respiratori
viral
panel
use
realtim
rtpcr
pcr
targetspecif
primer
extens
tspe
fluidbas
microspher
array
detect
viral
target
studi
respiratori
sampl
symptomat
adult
pediatr
patient
compar
detect
influenza
influenza
b
rsv
viral
isol
antigen
immunoassay
prodess
realtim
pcr
reagent
method
compar
specif
sensit
realtim
pcr
highest
rsv
influenza
liao
et
al
comparison
luminex
assay
rvp
lda
includ
faneg
respiratori
sampl
fortytwo
percent
sampl
posit
use
lda
versu
use
rvp
howev
virus
detect
lda
undetect
rvp
adenoviru
n
rsv
n
rare
except
low
concentr
addit
reduc
detect
adenoviru
may
due
vari
serotyp
distribut
seen
particular
geograph
locat
patient
popul
pabbaraju
et
al
research
report
sensit
adenoviru
use
rvp
mahoney
et
al
commerci
reagent
detect
respiratori
virus
becom
numer
reagent
repres
import
move
toward
identifi
larger
number
virus
quickli
convent
method
method
current
avail
detect
respiratori
virus
includ
immunolog
techniqu
fa
cultur
molecular
method
although
rapid
potenti
use
cohort
patient
immunolog
techniqu
specif
eia
lack
sensit
specif
compet
method
mention
fa
rapid
cultur
rapid
molecular
method
fa
result
subject
requir
train
personnel
perform
interpret
lack
sensit
cultur
molecular
amplif
cultur
method
allow
surviv
viabl
isol
could
use
studi
suscept
test
molecular
method
typic
regard
sensit
detect
virus
difficult
imposs
grow
also
like
detect
multivir
infect
molecular
method
detect
nonviabl
virus
therefor
posit
result
may
predict
whether
agent
communic
use
commerci
prepar
multiplex
molecular
reagent
close
attent
must
paid
limit
note
packag
insert
potenti
crossreact
instanc
primer
design
anneal
rhinoviru
may
also
anneal
enteroviru
therefor
posit
rhinoviru
reaction
may
confirm
anoth
method
distinct
consid
clinic
import
multiplex
assay
may
recommend
neg
result
confirm
method
luminex
falseneg
result
may
also
occur
due
emerg
undiscov
virus
polymorph
target
sequenc
instanc
molecular
reagent
detect
influenza
also
type
viru
use
reagent
influenza
viru
detect
type
determin
novel
strain
may
reason
case
sampl
would
need
secur
manipul
proper
government
public
health
author
would
need
contact
direct
cost
diagnost
test
import
consider
determin
assay
use
laboratori
import
includ
cost
expens
relat
perform
verif
studi
prior
test
implement
perform
characterist
fdaclear
kit
commerci
reagent
well
lda
must
verifi
clinic
laboratori
place
assay
clinic
servic
lda
typic
requir
extens
costli
valid
process
clinic
laboratori
commerci
produc
test
cost
molecular
assay
vari
wide
ongo
reagent
cost
per
test
molecular
lda
usual
less
molecular
commerci
assay
calcul
total
cost
per
assay
labor
involv
produc
aliquot
label
verifi
perform
qualiti
assay
reagent
place
servic
well
troubleshoot
larg
number
variabl
multiplex
assay
extens
includ
cost
per
test
calcul
time
packag
commerci
kitsreag
mislead
actual
cost
per
test
substanti
elev
vendor
propos
cost
expens
perform
qualiti
control
requir
regulatori
agenc
includ
packag
configur
increas
cost
per
test
laboratori
test
volum
allow
optim
use
reagent
also
note
patent
exist
genet
target
royalti
licens
fee
paid
perform
mani
molecular
diagnost
test
fee
often
includ
cost
commerci
kit
must
paid
separ
use
lda
perhap
prefer
way
use
new
multiplex
molecular
method
time
algorithm
use
convent
molecular
method
concept
discuss
later
section
chapter
assay
whether
fda
clear
vitro
test
lda
must
evalu
care
place
servic
clinic
laboratori
report
patient
result
perform
characterist
establish
assay
approv
clinic
use
ongo
qualiti
manag
practic
requir
written
standard
oper
procedur
outlin
practic
frequenc
perform
accept
criteria
action
taken
case
accept
criteria
obtain
document
result
necessari
correct
action
maintain
certainli
extern
posit
neg
templat
control
requir
run
ideal
posit
control
target
would
test
run
multiplex
reaction
two
three
target
run
posit
control
target
might
add
signific
amount
overal
cost
assay
howev
highli
multiplex
reaction
number
target
doubl
digit
cost
greatli
increas
control
suppli
kit
laboratori
must
obtain
produc
avail
commerci
control
limit
viral
particl
may
purchas
extract
dilut
concentr
detect
assay
laboratori
capabl
manufactur
oligonucleotid
plasmid
contain
target
sequenc
may
also
use
control
howev
case
laboratori
personnel
would
work
high
level
target
unless
high
level
contain
practic
risk
assay
contamin
high
reduc
cost
laboratori
test
new
lot
reagent
target
reagent
success
detect
intend
target
reagent
servic
posit
target
control
may
rotat
singl
posit
target
control
assay
laboratori
desir
requir
run
posit
target
control
run
cocktail
posit
target
control
made
multipl
target
run
singl
tube
number
target
per
tube
would
determin
empir
laboratori
specif
assay
laboratori
perform
fdaclear
assay
packag
insert
read
care
see
type
control
cocktail
allow
addit
posit
neg
control
run
new
lot
number
andor
shipment
reagent
must
verifi
proper
perform
addit
posit
control
intern
posit
control
ipc
ad
sampl
extract
taken
entir
procedur
monitor
reaction
integr
throughout
assay
accept
result
ipc
help
ensur
sampl
extract
properli
amplif
step
work
appropri
inhibitor
sampl
detect
step
accept
patient
sampl
may
vari
level
inhibitor
present
therefor
assay
valid
laboratori
establish
maximum
accept
ipc
ct
indic
signific
inhibitor
reaction
perform
assay
respiratori
virus
posit
neg
control
accept
sampl
neg
virus
test
ipc
fail
problem
could
either
extract
particular
sampl
inadequ
sampl
contain
inhibitor
inhibitor
truli
caus
ipc
failur
may
remedi
dilut
sampl
reextract
sampl
posit
one
target
virus
ipc
fail
may
result
high
viral
load
outcompet
ipc
target
dntp
reaction
compon
unless
contamin
suspect
posit
result
may
releas
cross
threshold
posit
control
monitor
period
usual
monthli
levyjen
plot
effect
mean
observ
shift
drift
result
presenc
trend
shift
trigger
comprehens
investig
assay
perform
includ
reagent
instrument
test
practic
quantit
measur
optic
densiti
od
ct
use
qualit
assay
defin
point
result
either
posit
neg
initi
set
laboratori
commerci
manufactur
assay
develop
cutoff
valu
reverifi
everi
month
major
chang
reagent
instrument
etc
laboratori
use
commerci
assay
vendorestablish
cutoff
extern
control
use
purpos
due
mutat
potenti
virus
import
monitor
strain
current
circul
whether
laboratori
assay
remain
abl
detect
strain
mahoney
laboratori
use
commerci
kit
manufactur
abl
provid
inform
laboratori
use
lda
one
way
accomplish
perform
period
search
onlin
sequenc
databas
respiratori
viru
sequenc
ad
sinc
design
lda
primersprob
lda
evalu
determin
adequ
detect
new
sequenc
may
need
redesign
assay
revalid
valid
physician
notifi
addit
virus
target
assay
new
strain
report
clinic
relev
time
year
inform
typic
avail
internet
listserv
variou
molecular
virolog
profession
organ
cdc
websit
also
latest
inform
concern
new
strain
respiratori
virus
safeti
sever
extract
method
use
guanidin
hydrochlorid
andor
guanidin
thiocyan
either
chemic
form
highli
reactiv
compound
mix
bleach
institut
polici
handl
dispos
chemic
close
follow
notif
train
anyon
work
reagent
potenti
danger
chemic
eg
ethidium
bromid
document
new
assay
instrument
introduc
laboratori
evalu
regard
potenti
safeti
issu
personnel
inform
proper
handl
storag
dispos
reagent
room
equip
outfit
item
ultraviolet
light
sourc
employe
adequ
train
safeti
precaut
practic
fewer
clinic
laboratori
use
radioact
laboratori
use
requir
adequ
train
personnel
handl
monitor
dispos
radioact
materi
document
train
maintain
qualit
test
typic
report
posit
neg
inhibitori
virus
target
assay
interpret
depend
cutoff
valu
establish
either
commerci
manufactur
laboratori
develop
assay
sampl
ct
cutoff
valu
report
neg
ct
cutoff
valu
report
posit
laboratori
may
elect
gray
zone
establish
around
cutoff
valu
would
repeat
assay
duplic
report
like
laboratori
report
report
multiplex
molecular
assay
target
respiratori
virus
indic
methodolog
use
refer
rang
result
avail
assay
vari
number
virus
capabl
detect
import
list
virus
target
report
proper
government
public
health
author
must
notifi
novel
strain
suspect
sever
method
detect
presenc
virus
respiratori
sampl
symptomat
individu
present
chapter
multiplex
molecular
method
implement
routin
use
mani
clinic
laboratori
method
sensit
speed
rapid
cultur
abil
detect
virus
difficult
imposs
cultur
abil
detect
multipl
virus
simultan
assay
high
complex
requir
capit
expenditur
may
feasibl
laboratori
test
algorithm
incorpor
sever
method
may
best
strategi
vital
consult
endus
group
includ
medic
staff
nurs
administr
implement
algorithm
design
would
depend
type
institut
patient
demograph
inform
go
use
patient
care
viral
preval
season
area
whether
detect
multipl
virus
import
mani
virus
target
assay
turnaround
time
isol
requir
suscept
test
one
algorithm
might
rapid
less
sensit
antigen
detect
test
would
use
first
might
particularli
use
geograph
region
high
preval
virus
detect
test
posit
result
use
rapid
test
would
report
test
sampl
would
stop
sampl
neg
result
would
test
sensit
assay
fa
sampl
neg
fa
would
test
molecular
diagnost
anoth
algorithm
might
fa
first
line
test
laboratori
might
opt
run
multiplex
assay
virus
consid
treatabl
high
clinic
impact
high
season
preval
influenza
rsv
laboratori
might
use
highli
multiplex
assay
target
avail
respiratori
viral
target
molecular
method
may
play
smaller
role
follow
knownposit
patient
infect
control
purpos
method
detect
viral
shed
day
even
week
clinic
symptom
subsid
cultur
result
neg
clinic
predict
valu
persist
posit
result
case
alway
well
defin
interpret
result
may
vari
depend
individu
institut
clinic
experi
molecular
techniqu
continu
show
improv
speed
accuraci
promis
becom
part
routin
detect
respiratori
virus
microarray
test
type
infecti
respiratori
agent
viral
bacteri
fungal
parasit
singl
respiratori
sampl
may
emerg
find
place
clinic
laboratori
customiz
format
may
allow
institut
design
assay
incorpor
particular
target
interest
given
popul
molecular
assay
rapid
less
expens
howev
convent
method
continu
use
mani
laboratori
immunofluoresc
antibodi
test
may
continu
import
rapid
screen
test
cell
cultur
phase
mani
clinic
laboratori
remain
import
order
cultiv
virus
vaccin
develop
analyz
virus
antigen
drift
perform
suscept
test
discov
emerg
pathogen
respiratori
infect
common
respons
signific
morbid
mortal
costli
term
lost
time
work
inappropri
use
antibiot
lengthi
hospit
stay
laboratori
detect
caus
agent
influenc
treatment
allow
appropri
infect
control
measur
potenti
save
time
money
promot
quicker
recoveri
patient
lower
risk
nosocomi
transmiss
organ
molecular
test
may
sensit
method
detect
respiratori
virus
method
shown
detect
multipl
virus
singl
sampl
often
method
describ
addit
detect
virus
difficult
imposs
grow
detect
nonviabl
organ
may
provid
addit
insight
diseas
provid
challeng
term
determin
clinic
signific
posit
result
like
mani
area
clinic
medicin
microbiolog
increas
use
molecular
diagnost
detect
respiratori
virus
rais
mani
new
question
laboratori
clinic
diagnostician
also
promis
mani
benefit
method
becom
increasingli
avail
routin
use
